Literature DB >> 19711898

Anionic nucleotide--lipids for in vitro DNA transfection.

Salim Khiati1, Nathalie Pierre, Soahary Andriamanarivo, Mark W Grinstaff, Nessim Arazam, Frédéric Nallet, Laurence Navailles, Philippe Barthélémy.   

Abstract

A family of new anionic nucleotide based lipids featuring thymidine-3'-monophosphate as nucleotide and 1,2-diacyl-sn-glycerol as lipid moiety for in vitro delivery of nucleic acids is described. The nucleotide lipids were prepared in three steps starting from 1,2-diacyl-sn-glycerols and 2'-deoxythymidine-3'-phosphoramidite. Gel electrophoresis experiments show that nucleotide-based lipid-DNA complexes are observed at Ca(2+) concentration higher than 1 mM. The transfection experiments carried out on mammalian Hek cell lines clearly demonstrate that the nucleotide moiety enhances the transfection efficacy of the natural anionic DPPA and DPPG lipids. SAXS studies indicate that the enhancement in transfection for nucleotide-based lipid formulations compared to those of the abasic natural derivative (DPPA) is likely due to the presence of the 2D columnar inverted hexagonal phase (H(II)) with a unit cell parameter a = 69.1 A in the nucleotide lipid formulations. The cytotoxicity studies of lipoplexes, evaluated against Hek cells using an MTS assay, revealed that palmitoyl nucleotide derivative complexes were not toxic even after 4 h of incubation, thus indicating that the anionic nucleotide lipids presented in this work offer an alternative to cationic transfection reagents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19711898     DOI: 10.1021/bc900163s

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  11 in total

Review 1.  Transfection by cationic gemini lipids and surfactants.

Authors:  M Damen; A J J Groenen; S F M van Dongen; R J M Nolte; B J Scholte; M C Feiters
Journal:  Medchemcomm       Date:  2018-07-17       Impact factor: 3.597

2.  The effect of charge-reversal amphiphile spacer composition on DNA and siRNA delivery.

Authors:  Xiao-Xiang Zhang; Carla A H Prata; Thomas J McIntosh; Philippe Barthélémy; Mark W Grinstaff
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

3.  Charge-reversal lipids, peptide-based lipids, and nucleoside-based lipids for gene delivery.

Authors:  Caroline M LaManna; Hrvoje Lusic; Michel Camplo; Thomas J McIntosh; Philippe Barthélémy; Mark W Grinstaff
Journal:  Acc Chem Res       Date:  2012-03-22       Impact factor: 22.384

4.  Lipid-mediated DNA and siRNA Transfection Efficiency Depends on Peptide Headgroup.

Authors:  Xiao-Xiang Zhang; Caroline M Lamanna; Richie E Kohman; Thomas J McIntosh; Xue Han; Mark W Grinstaff
Journal:  Soft Matter       Date:  2013-05-05       Impact factor: 3.679

5.  Charge-Conversion Strategies for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; Pintu Kanjilal; S Thayumanavan
Journal:  Adv Funct Mater       Date:  2021-03-31       Impact factor: 19.924

Review 6.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

7.  Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer.

Authors:  Hajer Ziouziou; Clément Paris; Sébastien Benizri; Thi Khanh Le; Claudia Andrieu; Dang Tan Nguyen; Ananda Appavoo; David Taïeb; Frédéric Brunel; Ridha Oueslati; Olivier Siri; Michel Camplo; Philippe Barthélémy; Palma Rocchi
Journal:  Pharmaceutics       Date:  2021-04-27       Impact factor: 6.321

Review 8.  Self-assembled nucleolipids: from supramolecular structure to soft nucleic acid and drug delivery devices.

Authors:  Vanessa Allain; Claudie Bourgaux; Patrick Couvreur
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

9.  Nucleoside-lipid-based nanocarriers for methylene blue delivery: potential application as anti-malarial drug.

Authors:  Koffi Kowouvi; Bruno Alies; Mathieu Gendrot; Alexandra Gaubert; Gaelle Vacher; Karen Gaudin; Joel Mosnier; Bruno Pradines; Philippe Barthelemy; Luc Grislain; Pascal Millet
Journal:  RSC Adv       Date:  2019-06-17       Impact factor: 4.036

10.  Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery.

Authors:  Sebastien Benizri; Ludivine Ferey; Bruno Alies; Naila Mebarek; Gaelle Vacher; Ananda Appavoo; Cathy Staedel; Karen Gaudin; Philippe Barthélémy
Journal:  Nanoscale Res Lett       Date:  2018-01-11       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.